Therapeutic paradox: nimodipine attenuates severe coronary spasm following coronary artery graft surgery in a high-risk vasoplegic cancer patient

Intern Med J. 2017 Feb;47(2):229-231. doi: 10.1111/imj.13325.

Authors

Krishnaswamy Sundararajan^{1

2}, Ross L Roberts-Thomson³, Adam J Nelson³, Peter J Psaltis³

Affiliations

¹ Intensive Care Unit, Royal Adelaide Hospital, University of Adelaide, Adelaide, South Australia, Australia.
² Discipline for Acute Care Medicine, University of Adelaide, University of Adelaide, Adelaide, South Australia, Australia.
³ Department of Cardiology, Royal Adelaide Hospital, University of Adelaide, Adelaide, South Australia, Australia.

PMID: 28201866
DOI: 10.1111/imj.13325

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Colorectal Neoplasms / pathology
Coronary Angiography
Coronary Artery Bypass / adverse effects*
Coronary Vasospasm / etiology
Coronary Vasospasm / therapy*
Coronary Vessels / surgery
Echocardiography
Electrocardiography
Humans
Intra-Aortic Balloon Pumping / methods
Liver Neoplasms / secondary
Male
Middle Aged
Nimodipine / therapeutic use*
Non-ST Elevated Myocardial Infarction / diagnostic imaging*
Postoperative Complications / etiology
Vasodilator Agents / therapeutic use*

Substances

Vasodilator Agents
Nimodipine